ayanapharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Ayana Pharma – Liposomal Therapeutics for |
| Description | Leadership Technology Product Market Investors Publications Contact Menu Leadership Technology Product Market Investors Publications Contact Ayana is a ph |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 5.154.240.28 |
| Location | Romania |
Related Websites
| Site | Rank |
More to Explore
ayanapharma.com Valuation
|
US$2,119,048
Last updated: 2023-04-30 14:18:32
ayanapharma.com has Semrush global rank of 4,994,841. ayanapharma.com has an estimated worth of US$ 2,119,048, based on its estimated Ads revenue. ayanapharma.com receives approximately 244,506 unique visitors each day. Its web server is located in Romania, with IP address 5.154.240.28. According to SiteAdvisor, ayanapharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,119,048 |
| Daily Ads Revenue | US$1,957 |
| Monthly Ads Revenue | US$58,682 |
| Yearly Ads Revenue | US$704,176 |
| Daily Unique Visitors | 16,301 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ayanapharma.com. | A | 3600 | IP: 5.154.240.28 |
| ayanapharma.com. | NS | 3600 | NS Record: ns1.upress.io. |
| ayanapharma.com. | NS | 3600 | NS Record: ns2.upress.io. |
| ayanapharma.com. | MX | 3600 | MX Record: 0 ayanapharma-com.mail.protection.outlook.com. |
| ayanapharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-04-30 14:18:32
| Leadership Technology Product Market Investors Publications Contact Menu Leadership Technology Product Market Investors Publications Contact Ayana is a pharmaceutical company focused on development of Liposomal Therapeutics for the treatment of cancer Founded in 2012 by Prof. Chezy Barenholz (co-inventor of Doxil® - Doxorubicin-HCl Liposomal Injection) Lead product LC101 (Doxorubicin-HCl Liposomal Injection) approved by FDA for treatment of Ovarian Cancer, Multiple Myeloma and AIDS-related Kaposi’s Sarcoma Secured FDA accredited, cGMP manufacturing facility to support commercial launch Strategic agreement with tier 1 pharma company for commercialization of LC101 in the U.S. market Overall $500m WW market opportunity with very few competitors due to high entry barriers (i.e. complex nonotechnology drug) Accomplished company leadership Leadership Technology Product Market Investors Publications Contact Menu Leadership Technology Product Market Investors Publications Contact |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Sat, 23 Oct 2021 08:56:29 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: http://www.ayanapharma.com/ HTTP/1.1 301 Moved Permanently Server: nginx Date: Sat, 23 Oct 2021 08:56:29 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://www.ayanapharma.com/ HTTP/2 200 server: nginx date: Sat, 23 Oct 2021 08:56:29 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding last-modified: Sat, 23 Oct 2021 02:01:58 GMT |
ayanapharma.com Whois Information
Domain Name: AYANAPHARMA.COM Registry Domain ID: 1809193552_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.arq.group Registrar URL: http://www.melbourneit.com.au Updated Date: 2020-04-19T05:57:13Z Creation Date: 2013-06-18T09:54:54Z Registry Expiry Date: 2023-06-18T09:54:54Z Registrar: Webcentral Group Limited dba Melbourne IT Registrar IANA ID: 13 Registrar Abuse Contact Email: abuse@melbourneit.com.au Registrar Abuse Contact Phone: +61342060102 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.UPRESS.IO Name Server: NS2.UPRESS.IO DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T20:20:04Z <<< |